BioCryst Pharmaceuticals Inc logo

BioCryst Pharmaceuticals Inc

NEW
FRA:BO1 (USA)   Ordinary Shares
€ 8.38 +0.034 (+0.41%) Aug 28
At Loss
Market Cap:
€ 2.15B ($ 2.50B)
Enterprise V:
€ 2.53B ($ 2.93B)
Volume:
10.00
Avg Vol (2M):
902.00
Trade In:

BioCryst Pharmaceuticals Inc Valuation Measures